Nigeria Pharmaceutical Registrations: 40 Products Expiring by July 2026
40 pharmaceutical product registrations are set to expire in Nigeria within the next 90 days (May-July 2026). Key products include generics and essential medicines.
A critical analysis of Nigeria's pharmaceutical regulatory landscape reveals that **40 active product registrations are set to expire within the next 90 days**, encompassing May, June, and July 2026. This data highlights the significant number of products that require timely re-registration to ensure continued market availability and compliance.
Overview of Expiring Registrations
The upcoming three months will see a concentrated period of registration renewals. The majority of these expirations are clustered in late June 2026, indicating a need for prompt action from the respective marketing authorization holders.
| Drug | Holder | Country | Expiry Date | Reg No |
|---|---|---|---|---|
| Always Platinum Ultra Thin Extra Long Sanitary Pads (Sanitary Pads) | Procter & Gamble Nig. Ltd | Nigeria | 30 May 2026 | 03-3277 |
| Tenex Capsule (Tenoxicam) | Phamatex Nigeria Limited | Nigeria | 03 Jun 2026 | B4-2973 |
| Fleming 1.2 g Injection Powder** (Amoxicillin (Amoxicillin Sodium); Clavulanic Acid (Potassium Clavulanate)) | Sanofi-Aventis Nigeria Limited | Nigeria | 23 Jun 2026 | 04-8410 |
| Erygen-250 Oral Suspension (Erythromycin (Erythromycin Ethylsuccinate)) | Geneith Pharmaceuticals Limited | Nigeria | 23 Jun 2026 | B4-5025 |
| Famagyl Suspension (Metronidazole (Metronidazole Benzoate)) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-1977 |
| Famagyl 400 Tablet (Metronidazole) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-2277 |
| Emxidine Gel (Chlorhexidine Digluconate) | Emzor Pharmaceutical Industries Limited | Nigeria | 23 Jun 2026 | B4-0593 |
| Emprofen Suspension (smpc null) (Ibuprofen) | Emzor Pharmaceutical Industries Limited | Nigeria | 23 Jun 2026 | A11-0105 |
| Axerem Suspension (Azithromycin (Azithromycin Dihydrate)) | Dony-Triumph and Company Nigeria Limited | Nigeria | 23 Jun 2026 | B4-4525 |
| Erygen-125 Oral Suspension (Erythromycin (Erythromycin Ethylsuccinate)) | Geneith Pharmaceuticals Limited | Nigeria | 23 Jun 2026 | B4-5026 |
| Excelxin 80/640 Suspension (Dihydroartemisinin; Piperaquine Phosphate) | Excel Charis Pharmaceutical Chemical Limited | Nigeria | 23 Jun 2026 | A4-100069 |
| Famagyl 200 Tablet (Metronidazole) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-2269 |
| Cika Diazepam Tablet (Diazepam) | Michelle Laboratories Limited | Nigeria | 23 Jun 2026 | A11-100139 |
| Amlodipine 10 mg Tablet (Amlodipine (Amlodipine Besilate)) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6505 |
| Chexol Tablets (Trihexyphenidyl Hydrochloride (Benzhexol Hydrochloride)) | Chez Resources Pharmaceutical Limited | Nigeria | 23 Jun 2026 | B4-3685 |
| Amlodipine 5 mg Tablet (Amlodipine (Amlodipine Besilate)) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6506 |
| Poccozith 250 Tablet (Azithromycin (Azithromycin Dihydrate)) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6451 |
| Paratex Syrup (Paracetamol) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-1594 |
| Propranolol 40 Tablet (Propranolol Hydrochloride) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6323 |
| Cika Ephedrine & Theophylline Tablet (Ephedrine Hydrochloride; Theophylline Hydrochloride) | Michelle Laboratories Limited | Nigeria | 23 Jun 2026 | A11-100146 |
| Clindess Vaginal Suppositories (Clindamycin (Clindamycin Phosphate); Clotrimazole) | Dony-Triumph and Company Nigeria Limited | Nigeria | 23 Jun 2026 | B4-5369 |
| Codisin Plus Tablet (Dihydroartemisinin; Piperaquine Phosphate) | Geneith Pharmaceuticals Limited | Nigeria | 23 Jun 2026 | A4-4917 |
| Amadol Injection** (Tramadol Hydrochloride) | Eutrix Pharmaceuticals Limited | Nigeria | 23 Jun 2026 | A4-1927 |
| Aceclofen Tablet 100 mg_ (Aceclofenac) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-2965 |
| Emaza Injection** (α-β Arteether) | Medicrown Nigeria Limited | Nigeria | 23 Jun 2026 | B4-5074 |
| Cardiotan 40/10 mg** (Amlodipine (Amlodipine Besilate); Telmisartan) | Swiss Pharma Nigeria Limited | Nigeria | 23 Jun 2026 | A4-100067 |
| Cardiotan 40/5 mg** (Amlodipine (Amlodipine Besilate); Telmisartan) | Swiss Pharma Nigeria Limited | Nigeria | 23 Jun 2026 | A4-100065 |
| Cardiotan 80/5 mg** (Amlodipine (Amlodipine Besilate); Telmisartan) | Swiss Pharma Nigeria Limited | Nigeria | 23 Jun 2026 | A4-100066 |
| Cefulvin Oral Suspension (Griseofulvin) | Chez Resources Pharmaceutical Limited | Nigeria | 23 Jun 2026 | B4-3105 |
| Cefuroxime 500 mg Tablets (Cefuroxime (Cefuroxime Axetil)) | Swiss Pharma Nigeria Limited | Nigeria | 23 Jun 2026 | A4-100068 |
| Amlodipine 5 mg Tablets** (Amlodipine (Amlodipine Besilate)) | World Wide Commercial Ventures Ltd | Nigeria | 23 Jun 2026 | A4-100061 |
| Ecoflocin Plus Tablets (Ofloxacin; Ornidazole) | Pinnacle Health Pharmaceutical & Stores Ltd | Nigeria | 23 Jun 2026 | B4-2098 |
| Pilotab Caplet (Ciprofloxacin (Ciprofloxacin Hydrochloride)) | Phamatex Nigeria Limited | Nigeria | 23 Jun 2026 | B4-2270 |
| Fluconazole 200 mg Capsule** (Fluconazole) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6504 |
| RGI Cipro Caplet 500 mg (Ciprofloxacin (Ciprofloxacin Hydrochloride)) | Richygold International Limited | Nigeria | 23 Jun 2026 | A4-2571 |
| M & B Ibuprofen** (Ibuprofen) | May & Baker Nigeria PLC | Nigeria | 23 Jun 2026 | A11-0117 |
| Poccozith 500 Tablet (Azithromycin (Azithromycin Dihydrate)) | First J. Pocco Pharmacy Limited | Nigeria | 23 Jun 2026 | B4-6508 |
| Coversyl Plus 5 mg/1.25 mg (Perindopril Arginine; Indapamide) | Caesar & Jones Nigeria Ltd | Nigeria | 23 Jun 2026 | B4-4159 |
| Donystatin Cream (Nystatin) | Dony-Triumph and Company Nigeria Limited | Nigeria | 23 Jun 2026 | B4-5863 |
| Emzoclav** (Amoxicillin (Amoxicillin Trihydrate); Clavulanic Acid (Potassium Clavulanate)) | Emzor Pharmaceutical Industries Limited | Nigeria | 23 Jun 2026 | A4-8986 |
Key Product Categories and Holders Affected
The expiring registrations span a range of therapeutic areas and product types, from essential antibiotics to antimalarials, cardiovascular drugs, and anti-inflammatory medications. Notably, several major pharmaceutical players in Nigeria have products on this list:
- Phamatex Nigeria Limited: With 7 expiring products, Phamatex has a significant number of renewals due. These include essential drugs like Metronidazole (Famagyl variants), Paracetamol (Paratex Syrup), and Aceclofenac.
- Emzor Pharmaceutical Industries Limited: Emzor, a prominent local manufacturer, has 3 products, including Ibuprofen (Emprofen Suspension) and Amoxicillin/Clavulanic Acid (Emzoclav).
- First J. Pocco Pharmacy Limited: This company has 6 products expiring, featuring critical generics such as Amlodipine (5mg and 10mg tablets), Azithromycin (Poccozith 250mg and 500mg), Fluconazole, and Propranolol.
- Swiss Pharma Nigeria Limited: Swiss Pharma has 4 expiring products, including combination cardiovascular drugs (Cardiotan variants) and Cefuroxime 500 mg tablets, an important antibiotic.
- Geneith Pharmaceuticals Limited: Geneith has 3 products, including Erythromycin oral suspensions and an antimalarial combination (Codisin Plus).
- Dony-Triumph and Company Nigeria Limited: This company also has 3 products, including Azithromycin suspension and Clindamycin/Clotrimazole vaginal suppositories.
- Sanofi-Aventis Nigeria Limited: A key international player, Sanofi-Aventis has 'Fleming 1.2 g Injection Powder', a potent Amoxicillin/Clavulanic Acid combination, nearing expiration.
Regulatory Implications of Lapsed Registrations
Forgetting to renew a product registration can have severe consequences for pharmaceutical companies. The Nigerian regulatory authority, NAFDAC, strictly enforces product registration requirements. Should a registration lapse, the product can no longer be legally manufactured, imported, distributed, or sold in Nigeria. This can lead to:
- Market Withdrawal: Immediate requirement to pull all stock from the market, leading to significant financial losses.
- Supply Chain Disruptions: Unavailability of essential medicines, impacting patient access and public health.
- Financial Penalties: NAFDAC can impose substantial fines for non-compliance.
- Reputational Damage: Loss of trust among healthcare providers, patients, and regulatory bodies.
- Lengthy Re-registration Process: Reinstating a lapsed product typically involves a new registration application, which can be as arduous and time-consuming as the initial process, potentially taking months or even years.
It is crucial for marketing authorization holders to initiate the renewal process well in advance of the expiry date, generally six to twelve months prior, to account for potential delays in documentation, submission, and regulatory review.
Impact on Essential Medicines
The list includes several products that could be considered essential medicines or critical generics. Examples include broad-spectrum antibiotics like Amoxicillin/Clavulanic Acid (Fleming, Emzoclav), Azithromycin (Axerem, Poccozith), Erythromycin (Erygen), and Ciprofloxacin (Pilotab, RGI Cipro). Metronidazole (Famagyl) is also a widely used antibiotic/antiprotozoal. Antihypertensive drugs like Amlodipine and anti-inflammatory agents like Ibuprofen (Emprofen, M & B Ibuprofen) are also on the list. The potential for these products to be temporarily removed from the market due to lapsed registrations could have direct implications for patient care and treatment accessibility across Nigeria.
Strategic Importance for Manufacturers
Manufacturers holding these registrations must prioritize their renewal strategies. Given the volume expiring in June, proactive engagement with NAFDAC and meticulous preparation of renewal dossiers are paramount. This involves ensuring all supporting documents are current, fees are paid, and any post-marketing commitments have been fulfilled. For companies with multiple expiring products, like Phamatex and First J. Pocco Pharmacy, a coordinated approach is essential to manage the workload effectively and avoid any oversight.
AfriReg Pro helps regulatory teams automate the tracking of product registration expiries, ensuring timely renewals and seamless compliance across African markets, thereby mitigating risks and safeguarding market access.